Proven. Effective. Comfortable.

  • As monotherapy, BETIMOL® provides proven efficacy for consistent IOP control4
  • As adjunctive therapy, BETIMOL® delivers significant reduction in IOP levels when added to Xalatan® (P<0.001)3
  • Less post-installation blurred vision than timolol gel solution2, 7
  • Patients reported less stinging and burning compared to Istalol® 2 Prescribe

Prescribe BETIMOL®: Comfortable and effective IOP control for your patients


To see full Prescribing and Safety Information for Betimol® please click here.

Important Safety Information

The most commonly reported ocular side effect was stinging and burning.

BETIMOL® is contraindicated in patients with overt heart failure, cardiogenic shock, sinus bradycardia, second- or third-degree atrioventricular block, bronchial asthma or history of bronchial asthma, severe chronic obstructive pulmonary disease, or hypersensitivity to any component of this product.


1. Mundorf TK.Therapeutic options for glaucoma:beta blockers remain a mainstay therapy for the medical management of glaucoma. Ophthalmol Manage. April 2008; 15:49-52.

2. Sonty S, Mundorf TK, Stewart JA, Stewart WC. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study. Clinical Therapeutics. 2009;31:2063-2071

3. Stewart WC, Day DG, Sharpe ED, Dubiner HB, Holmes KT, Stewart JA. Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost. Am J Ophthalmol. 1999;128:692-696.

4. Stewart WC, Leland TM, Cate EA, Stewart JA. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure. J Glaucoma. 1998;7:402-407.

5. DuBiner HB, Hill R, Kaufman H, et al. Timolol hemihydrate vs timolol maleate to treat ocular hypertension and open-angle glaucoma. Am J Ophthalmol.1996;121:522-528.

6. Beckers HJ, Schouton JS, Webers CA, van de Valk R, Hendrikse F. Side effects of commonly used glaucoma medication: comparison of tolerability, chance of discontinuation, and patient satisfaction. Graefes Arch Clin Exp Oph 2008: 246:1485-1490.

7. Stewart WC, Leland TM, Cate EA, Stewart JA. Efficacy and safety of timolol solution once daily vs. timolol gel in treating elevated IOP. J Glaucoma 1998;7:402-447.

8. Stewart WC, Stewart JA, Holmes KT, Leech JN. Differences in ocular surface irritation between timolol hemihydrate and timolol maleate. Am J Ophthalmol. 2000;130:712-716.